Product
Supplier
Encyclopedia
Inquiry
Home > Chemicals Market Price & Insight > Ofloxacin Market Price & Analysis > Featured News - Ofloxacin > North China Pharmaceutical's 'R&D and demonstration application of key technologies for anti-drug-resistant bacteria drug Mupirocin' successfully passed the acceptance
— Share —

North China Pharmaceutical's 'R&D and demonstration application of key technologies for anti-drug-resistant bacteria drug Mupirocin' successfully passed the acceptance

healthoo 2021-08-19
On August 11, 2021, the Hebei Province Science and Technology Plan Project undertaken by North China Pharmaceutical Group New Drug Research and Development Co., Ltd.

Please sign in to view all content or subscribe.

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.